The influence of drug-like concepts on decision-making in medicinal chemistry

  title={The influence of drug-like concepts on decision-making in medicinal chemistry},
  author={P. Leeson and Brian Springthorpe},
  journal={Nature Reviews Drug Discovery},
  • P. Leeson, Brian Springthorpe
  • Published 2007
  • Medicine
  • Nature Reviews Drug Discovery
  • The application of guidelines linked to the concept of drug-likeness, such as the 'rule of five', has gained wide acceptance as an approach to reduce attrition in drug discovery and development. However, despite this acceptance, analysis of recent trends reveals that the physical properties of molecules that are currently being synthesized in leading drug discovery companies differ significantly from those of recently discovered oral drugs and compounds in clinical development. The consequences… CONTINUE READING
    1,522 Citations

    Figures and Topics from this paper

    The significance of acid/base properties in drug discovery.
    • 131
    The influence of lead discovery strategies on the properties of drug candidates
    • 435
    Finding the sweet spot: the role of nature and nurture in medicinal chemistry
    • 272
    • PDF
    The application of in silico drug-likeness predictions in pharmaceutical research.
    • 134
    Recent Advances in Physicochemical and ADMET Profiling in Drug Discovery
    • 37
    Drug efficiency: a new concept to guide lead optimization programs towards the selection of better clinical candidates
    • 42
    Medicinal chemistry: Exploring the third dimension
    • 15


    Drug-like properties: guiding principles for design - or chemical prejudice?
    • 63
    A guide to drug discovery: The role of the medicinal chemist in drug discovery — then and now
    • 201
    • PDF
    Lead- and drug-like compounds: the rule-of-five revolution.
    • C. Lipinski
    • Biology, Medicine
    • Drug discovery today. Technologies
    • 2004
    • 1,776
    Organic Chemistry in Drug Discovery
    • 87
    • PDF
    Identification and evaluation of molecular properties related to preclinical optimization and clinical fate.
    • J. Blake
    • Computer Science, Medicine
    • Medicinal chemistry (Shariqah (United Arab Emirates))
    • 2005
    • 33
    Characteristic physical properties and structural fragments of marketed oral drugs.
    • 309
    Predicting ADME properties and side effects: the BioPrint approach.
    • 158